Course Schedule and Structure

Course Structure

This course incorporates various delivery methods in order to provide you with some key theoretical topics for psychedelic-assisted therapy, using an evidence-based approach and best practices that will promote your learning retention and engagement. We aim to provide you with sufficient opportunities to practice relevant skills that will help you on your journey to becoming a competent clinician with psychedelic-assisted therapy.

Pre-work

Each module has pre-work that must be completed prior to attending the live session. In the pre-work, there is text for you to read and videos for you to watch so that you have sufficient foundational knowledge to get the most out of the live sessions.

Live Sessions

The primary goal of the live sessions is to practice the key skills and competencies using the online material as your foundation. Please come to class with the intention of participating and engaging with your fellow learners in order to get the most out of these sessions.

Assessments

Throughout the course, there will be various assessments to evaluate your knowledge, skills, and competencies that you have gained from the course. On the upcoming Assessment Overview page, you will learn about the course assessments and what you’ll need to successfully complete them.

Discussions with Flip

Prior to joining Flip, please read more about this third-party platform in the Welcome to Numinus Training module.

  1. Select the join classroom button at the bottom of this section

  2. Create a new account or login with Microsoft, Google, or Apple

  3. Select Introduce Yourself and record a quick introduction of yourself, your experience, and your motivation for taking the course.

Course Schedule

Before we dive into the course content, take a look at the course schedule to give yourself an idea of what is expected of you each module.

Course Access Begins

Monday March 20, 2023

Course End Date

Tuesday May 2, 2023

Final Assignment Submission Date

Sunday May 7, 2023

Course Access Ends

Wednesday September 20, 2023

Time Zones

If you are not located in the Pacific Time, Eastern Time, or Central European Time, please refer to the Time Zone Converter to ensure that you don’t miss deadlines or any virtual classes.

Note

You should complete all of the prework before the associated live session. The live sessions will focus on some of the topics you read about or watched from the pre-work.

Topics

  • DSM
  • Transdiagnostic perspectives
  • Biases in the DSM
  • Research Domain Criteria

Learning Outcomes

  • Describe the role of the DSM and ICD in the diagnosis of mental illness.

  • Examine how the DSM has contributed to the oppression and marginalization of social groups on the basis of race, gender, and other social factors.

  • Apply the Numinus care model to transdiagnostic approaches to mental health.

  • Examine indication-based and transdiagnostic-based approaches to psychopathology.

  • Critically evaluate the Research Domain Criteria as an alternative to the DSM model.

  • Explain the transdiagnostic potential of psychedelic-assisted therapy.

Virtual Classes

  • Tuesday March 28

    • 9:00AM to 12:00PM PT

    • 12:00PM to 3:00PM ET

    • 6:00PM to 9:00PM CET

Assessments Due

  • Module 1 Knowledge Check due before March 28

Topics

  • Depression
  • Psychedelic-assisted therapy for depression
  • Anxiety
  • Anxiety-related disorders
  • Shared transdiagnostic factors for anxiety and depression
  • Psychedelic-assisted therapy for anxiety

Learning Outcomes

  • Identify which psychedelic medicines have been used for psychedelic-assisted therapy in the treatment of depression and anxiety.

  • Describe key evidence-based literature supporting the use of psychedelic-assisted therapy in the treatment of anxiety and depression.

  • Compare the DSM criteria and transdiagnostic factors of anxiety and depression.

  • Justify the rationale for using a transdiagnostic approach to the treatment of anxiety and depression.

  • Describe the similarities and differences between anxiety disorders and anxiety-related disorders such as obsessive-compulsive and related disorders and trauma- and stressor-related disorders.

Virtual Classes

  • Tuesday April 4, 2023

    • 9:00AM to 12:00PM PT

    • 12:00PM to 3:00PM ET

    • 6:00PM to 9:00PM CET

Assessments Due

  • Module 2 Knowledge Check due before April 4

Topics

  • PTSD
  • Transdiagnostic perspectives of post-traumatic stress
  • Psychedelic-assisted therapy for post-traumatic stress
  • Shame

Learning Outcomes

  • Identify which psychedelic medicines have been used for psychedelic-assisted therapy in the treatment of post-traumatic stress.
  • Describe key evidence-based literature supporting the use of psychedelic-assisted therapy in the treatment of post-traumatic stress.
  • Compare the DSM criteria and use a transdiagnostic framework understanding for post-traumatic stress.
  • Justify the rationale for using a transdiagnostic approach to the treatment of post-traumatic stress.
  • Describe the role that shame plays in post-traumatic stress and therapeutic approaches to working with shame.

Virtual Classes

  • Tuesday April 11, 2023

    • 9:00AM to 12:00PM PT

    • 12:00PM to 3:00PM ET

    • 6:00PM to 9:00PM CET

Assessments Due

  • Module 3 Knowledge Check due before April 11

Topics

  • Existential distress
  • Treatment plans for demoralization and existential distress
  • Psychedelic-assisted therapy for demoralization and existential distress

Learning Outcomes

  • Apply existential therapy, supportive and expressive therapy, and mindfulness to psychedelic-assisted therapy for clients with chronic and serious illness.

  • Explain the difference between depression and demoralization for the purposes of treating existential distress.

Virtual Classes

  • Tuesday April 18, 2023

    • 9:00AM to 12:00PM PT

    • 12:00PM to 3:00PM ET

    • 6:00PM to 9:00PM CET

Assessments Due

  • Module 4 Knowledge Check due before April 18

Topics

    Substance use disorders Psychedelic-assisted therapy for substance use disorders Motivational enhancement therapy Relapse prevention

Learning Outcomes

  • Identify which psychedelic medicines have been used for psychedelic-assisted therapy in the treatment of substance use disorders.

  • Describe key evidence-based literature supporting the use of psychedelic-assisted therapy in the treatment of substance use disorders.

  • Demonstrate a rudimentary understanding of motivational interviewing and motivational enhancement therapy and how it relates to psychedelic-assisted therapy in the treatment of substance use disorders.

  • Explain the importance of relapse prevention skills as an important part of the treatment of substance use disorders.

Virtual Classes

  • Tuesday April 25, 2023

    • 9:00AM to 12:00PM PT

    • 12:00PM to 3:00PM ET

    • 6:00PM to 9:00PM CET

Assessments Due

  • Module 5 Knowledge Check due before April 25

Topics

  • Complex PTSD
  • Complex cases for psychedelic-assisted therapy
  • Wrapping everything together

Learning Outcomes

  • Describe the complexities involved with complex PTSD and how to develop a treatment plan that includes a transdiagnostic lens.

Virtual Classes

  • Tuesday May 2, 2023

    • 9:00AM to 12:00PM PT

    • 12:00PM to 3:00PM ET

    • 6:00PM to 9:00PM CET

Assessments Due

  • Module 6 Knowledge Check due before May 2